We learned a lot about salvage therapy a few days back. Let’s continue our multiple myeloma education and study the ABCs of therapy for newly diagnosed patients.
I found this excellent review of induction therapy options prior to transplant from our friends at Chemotherapy Adviser:
Optimal Induction Therapy for Multiple Myeloma
Three pages of detail, including several helpful charts which outline which therapy might be best for different patients with different co-morbidities and/or genetic considerations.
CLICK HERE to access the article. Here is the case study summary:
For this patient without comorbidities and only mild renal dysfunction, the optimal induction would probably be lenalidomide, bortezomib, and dexamethasone for four to six cycles and proceed to stem cell transplantation. In summary, the optimal treatment of multiple myeloma today requires a multidisciplinary approach. The advent of novel therapeutic agents has opened new avenues of therapy, which although extremely effective, can be associated with significant toxicities. A team approach to treatment of the multiple myeloma patient goes a long way in reducing the potential for serious complications during induction and consolidation therapy. Appropriate education of caregivers and healthcare providers, particularly regarding symptom recognition and reporting, as well as careful monitoring by the treatment team of physicians, nurses, and pharmacists, are essential to optimize outcomes and reduce complications.
Even if you don’t have time to spend studying this on a holiday weekend, file-it-away for future reference.
Feel good and keep smiling! Pat